相关实验视频

Updated: May 17, 2025

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

通过CD47阻断介导的巨细胞细胞分裂来治疗子宫内膜癌的免疫疗法

Kerem Yucebas¹, Sooah Ko¹, Jinyu Zhou¹

¹Department of Obstetrics, Gynecology and Women's Health, School of Medicine, University of Missouri, Columbia, MO 65211, USA.

|May 15, 2025

概括

用抗体阻止CD47在癌细胞上,可以增强巨细胞的包裹. 这种方法在小鼠模型中显著降低了瘤负担,为子宫内膜癌提供了有前途的新疗法.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
癌症生物学癌症生物学

背景情况:

癌细胞上的CD47通过与巨细胞上的SIRPα结合来抑制巨细胞的细胞分裂.
人类子宫内膜癌细胞 (hECCs) 显示CD47表达的增加.
在子宫内膜癌中,瘤微环境被瘤相关的巨细胞透.

研究的目的:

研究向子宫内膜癌中CD47-SIRPα通路的治疗潜力.
评估抗CD47单克隆抗体 (mAb) 在促进hECCs的巨介导的细胞分裂中的有效性.

主要方法:

使用hECC和巨细胞进行体外细胞分析.
在体内研究中,使用基因工程对子宫内膜癌的小鼠模型.
一种抗CD47 mAb的全身和 in situ 管理.

主要成果:

抗CD47 mAb治疗在体外显著增强了巨细胞对hECCs的细胞分解.
系统和局部抗CD47 mAb治疗都导致小鼠模型中的瘤负担显著减少.
该研究在子宫内膜癌模型中证明了CD47阻断的临床前有效性.

结论:

CD47阻断是一种可行的策略,可以增强子宫内膜癌细胞的巨细胞化.
抗CD47 mAb疗法显示出作为子宫内膜癌的新疗法治疗方法的潜力.
针对CD47-SIRPα轴是治疗子宫内膜癌的一个有希望的途径.

关键词:

生物科学生物科学 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 医学科学医学科学医学科学这是子宫内膜癌的癌症.免疫疗法免疫疗法巨细胞是一个巨细胞.发酵细胞的形成发酵细胞的形成

更多相关视频

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Phagocytosis of Apoptotic Cells

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...